1. J.D. Tucker, D.A. Eastmond, L.G. Littlefield, Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies, in: P. Toniolo, P. Boffetta, D.E.G. Shuker, N. Rothman, B. Hulka, N. Pearce (Eds.), Application of Biomarkers in Cancer Epidemiology, International Agency for Research on Cancer, Lyon, 1997, pp. 185–200.
2. Chromosome aberrations and cancer;Solomon;Science,1991
3. Chromosomal translocations in human cancer;Rabbitts;Nature,1994
4. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage;Hagmar;Cancer Res.,1994
5. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study;Bonassi;Cancer Genet. Cytogenet.,1995